Prelude Therapeutics, Inc. (PRLD)
2.86
+0.09
(+3.25%)
USD |
NASDAQ |
Feb 24, 16:00
2.89
+0.03
(+1.05%)
After-Hours: 20:00
Prelude Therapeutics Shareholders Equity (Annual) : 131.46M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| BioLife Solutions, Inc. | 348.91M |
| Immunome, Inc. | 181.16M |
| Incyte Corp. | 5.167B |
| Aclaris Therapeutics, Inc. | 155.55M |
| Relay Therapeutics, Inc. | 777.79M |